Implementation Guide CH VACD
5.0.0 - trial-use
This page is part of the CH VACD (R4) (v5.0.0: STU 5) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Document Subject
Unable to resolve subject ''
Document Content
Id: A-D1-P-C1-Composition
Identifier: urn:ietf:rfc:3986#urn:uuid:b505b90a-f241-41ca-859a-b55a6103e753
Status: Final
Code: Immunization record (http://snomed.info/sct#41000179103)
Patient: Patient/TC-patient Wegmueller Monika
Date: June 1, 2021
Authors:
Patient/TC-patient Wegmueller Monika |
Confidentiality: null Normal (qualifier value) (http://snomed.info/sct#17621005)
Sections:
Immunization Administration |
Code: Hx of Immunization (http://loinc.org#11369-6)
Entries:
Immunization/TCA01-IMMUN1-patient |
Entry 1 - fullUrl = http://test.fhir.ch/r4/Composition/A-D1-P-C1-Composition
Resource Composition:
Immunization Administration
Id: A-D1-P-C1-Composition
Identifier: urn:ietf:rfc:3986#urn:uuid:b505b90a-f241-41ca-859a-b55a6103e753
Status: Final
Code: Immunization record (http://snomed.info/sct#41000179103)
Patient: Patient/TC-patient Wegmueller Monika
Date: June 1, 2021
Authors:
Patient/TC-patient Wegmueller Monika
Confidentiality: null Normal (qualifier value) (http://snomed.info/sct#17621005)
Sections:
Immunization Administration
Entry 2 - fullUrl = http://test.fhir.ch/r4/Patient/TC-patient
Resource Patient:
Generated Narrative: Patient TC-patient
Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
Contact Detail
- ph: tel:+41.32.685.12.34(Home)
- Leidensweg 10 Specimendorf 9876 CH
Entry 3 - fullUrl = http://test.fhir.ch/r4/Practitioner/TC-HCP1-C1
Resource Practitioner:
Generated Narrative: Practitioner TC-HCP1-C1
identifier: GLN/7601888888884
active: true
name: Peter Müller
telecom: ph: tel:+41.32.234.55.66(Work), fax: fax:+41.32.234.55.67(Work), mailto:allzeit.bereit@gruppenpraxis.ch, http://www.gruppenpraxis.ch
address: Grabenstrasse 2 Zürich 8005 CH
Entry 4 - fullUrl = http://test.fhir.ch/r4/Organization/TC-ORG1
Resource Organization:
Generated Narrative: Organization TC-ORG1
identifier: GLN/7601777777718
name: Gruppenpraxis Müller
contact
telecom: ph: tel:+41.32.234.55.66(Work), fax: fax:+41.32.234.55.67(Work), mailto:bereit@gruppenpraxis.ch, http://www.gruppenpraxis.ch
address: Grabenstrasse 2 Zürich ZH 8005 CH
Entry 5 - fullUrl = http://test.fhir.ch/r4/PractitionerRole/TC-HCP1-ORG1-ROLE-performer
Resource PractitionerRole:
Generated Narrative: PractitionerRole TC-HCP1-ORG1-ROLE-performer
active: true
practitioner: Practitioner Peter Müller
organization: Organization Gruppenpraxis Müller
Entry 6 - fullUrl = http://test.fhir.ch/r4/Immunization/TCA01-IMMUN1-patient
Resource Immunization:
Generated Narrative: Immunization TCA01-IMMUN1-patient
Author of the content: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
CH VACD Extension Immunization Medication Reference: Medication HAVRIX 1440 Inj Susp
identifier:
urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/acc1f090-5e0c-45ae-b283-521d57c3aa2fstatus: Completed
vaccineCode: Havrix 1440
lotNumber: AHAVB946A
patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
occurrence: 2021-06-01
route: Intramuscular use
Performers
Actor PractitionerRole note: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-01)
ProtocolApplieds
TargetDisease Viral hepatitis, type A (disorder)
Entry 7 - fullUrl = http://test.fhir.ch/r4/Medication/TC-IMMUN-MEDIC-HAVRIX1440
Resource Medication:
Generated Narrative: Medication TC-IMMUN-MEDIC-HAVRIX1440
identifier:
urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/359000dc-2cee-4a6e-ab05-577f558840e2code: HAVRIX 1440 Inj Susp
status: Active
ingredient
Batches
LotNumber AHAVB946A
Entry 8 - fullUrl = http://test.fhir.ch/r4/Organization/TC-ORG-GSK
Resource Organization:
Generated Narrative: Organization TC-ORG-GSK
identifier: GLN/7601001000674
name: GlaxoSmithKline AG
contact
telecom: ph: tel:+41 31 862 21 11(Work), fax: fax:+41 31 862 22 00(Work), mailto:swiss.info@gsk.com, https://www.gsk.com
address: Talstrasse 3-5 Münchenbuchsee BE 3053 CH